18:23:26 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-07 Kvartalsrapport 2024-Q3
2024-08-21 Kvartalsrapport 2024-Q2
2024-05-16 X-dag ordinarie utdelning STENO 0.00 DKK
2024-05-15 Årsstämma 2024
2024-05-02 Kvartalsrapport 2024-Q1
2024-02-22 Bokslutskommuniké 2023
2024-02-05 Extra Bolagsstämma 2024
2023-11-09 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-06-20 Kvartalsrapport 2023-Q1
2023-06-13 Extra Bolagsstämma 2023
2023-05-22 X-dag ordinarie utdelning STENO 0.00 DKK
2023-02-23 Bokslutskommuniké 2022
2022-11-18 Extra Bolagsstämma 2022
2022-11-09 Kvartalsrapport 2022-Q3
2022-08-18 Kvartalsrapport 2022-Q2
2022-05-20 X-dag ordinarie utdelning STENO 0.00 DKK
2022-05-19 Årsstämma 2022
2022-05-05 Kvartalsrapport 2022-Q1
2022-02-24 Bokslutskommuniké 2021
2021-11-04 Kvartalsrapport 2021-Q3
2021-08-19 Kvartalsrapport 2021-Q2
2021-05-21 X-dag ordinarie utdelning STENO 0.00 DKK
2021-05-20 Årsstämma 2021
2021-05-06 Kvartalsrapport 2021-Q1
2021-02-25 Bokslutskommuniké 2020
2020-11-05 Kvartalsrapport 2020-Q3
2020-08-20 Kvartalsrapport 2020-Q2
2020-05-15 X-dag ordinarie utdelning STENO 0.00 DKK
2020-05-14 Årsstämma 2020
2020-05-07 Kvartalsrapport 2020-Q1
2020-02-26 Bokslutskommuniké 2019
2019-11-06 Kvartalsrapport 2019-Q3
2019-08-20 Kvartalsrapport 2019-Q2
2019-05-07 Kvartalsrapport 2019-Q1
2019-02-21 Bokslutskommuniké 2018

Beskrivning

LandDanmark
ListaFirst North Denmark
SektorHälsovård
IndustriLäkemedel & Handel
Stenocare är verksamt inom hälsovårdsindustrin. Bolaget är specialiserat inom utveckling av medicinsk cannabis. Stenocare är en av de första aktören att ha påbörjat försäljning av medicinska cannabisoljor i Danmark. Bolaget kommer framöver även vända sig till övriga europeiska marknader med sitt produktutbud. Stenocares huvudkontor ligger i Randers.
2024-06-18 13:31:57

STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK
TICKER: STENO

Stenocare TO2 Warrant trading will end close of business June 19. To benefit from the discounted share price of DKK 3.16 each, subscribers need to own TO2 Warrants (ticker: STENO TO2).

Stenocare is currently offering a time-limited share issue for owners of TO2 Warrants. These warrants can be purchased and/or sold until the deadline of June 19, 2024, at 17:00 Central European Summer Time.

The TO2 Warrants can be used to subscribe to (purchase) the new Stenocare shares at a discounted price of DKK 3.16 each during the exercise period from June 10 to June 21. TO2 Warrant owners who decide to subscribe before this deadline must instruct their bank to exercise (use) the TO2 Warrants.

Please note that TO2 Warrants not exercised (used) before June 21 will be void and cannot be traded after the deadline.

The investment brochure

To inform existing shareholders of Stenocare and other investors and stakeholders about the exercise of TO2 warrants, an investment brochure has been prepared. This brochure contains details about the Company, its business, products and strategy. Information is also available on the investor website of Stenocare https://stenocare.com/share-issue-to2-2024/

On the Stenocare Facebook wall, there are also two 15 minutes interviews with Proinvestor.com and STOKK.IO - that provide more information about the TO2 Warrant and the company: https://www.facebook.com/stenocare

The summary

Summarized terms for the warrants of series TO2:
  • Exercise price: 3.16 DKK per share - ticker: [STENO TO 2] / ISIN DK0062493615
  • Exercise period: 10 June 2024 - 21 June 2024 (both days included)
  • Last day of trading warrants of series TO2: 19 June 2024
  • Issue volume: 1,712,999 warrants of series TO2
  • Dilution: Up to 8.5 percent